| 000 | 00868 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517170958.0 | ||
| 264 | 0 | _c20190626 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000004369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Ho Jin | |
| 245 | 0 | 0 |
_aImmune checkpoint inhibitor therapy: A double-edged sword? _h[electronic resource] |
| 260 |
_bNeurology _c09 2017 |
||
| 300 |
_a1101-1102 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMyasthenia Gravis |
| 650 | 0 | 4 | _aMyocarditis |
| 650 | 0 | 4 | _aMyositis |
| 650 | 0 | 4 | _aNivolumab |
| 700 | 1 | _aEvoli, Amelia | |
| 773 | 0 |
_tNeurology _gvol. 89 _gno. 11 _gp. 1101-1102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000004369 _zAvailable from publisher's website |
| 999 |
_c27478865 _d27478865 |
||